Access Collective Patients Safety 
Cannabis Law Report
DECEMBER 11, 2021
The UK’s first and highest-rated medical cannabis clinic, Sapphire Medical Clinics , has today announced that it is reducing the cost of its consultations and appointments for patients enrolled through the Sapphire Access Scheme. The Sapphire Access Scheme will be open to an additional 2,000 patients in the UK.
MMJ Recs
OCTOBER 2, 2023
California has been a trailblazer in the realm of medical marijuana, offering patients access to a variety of treatment options. Patients must first schedule an appointment with a licensed medical professional who can evaluate their medical history and condition. In 1996, the state became the first in the U.S.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
NORML
MAY 19, 2020
In their letter , AGs opine: “The current predicament of a rapidly expanding national marketplace without access to the national banking systems has resulted in an untenable situation. We stress that current legislative models are available to fix this situation.
Cannabis Law Report
DECEMBER 14, 2021
A WARNING has been issued by a local medical cannabis clinic that it will ban patients trying to use what it called ‘underhand’ means to try to obtain ‘double medication’. For anyone to try and receive double the medication by being underhand is unacceptable and could result in patients being banned from the clinic/s.
Veriheal
FEBRUARY 6, 2024
These new proposals are designed to expand access to medical cannabis for NJ MMJ patients. ” Other states with comparable populations, like Arizona and Michigan, have 10 to nearly 20 times the number of medical cannabis patients. New Jersey Lawmakers Proposal for Positive Cannabis Reform New Jersey Governor Philip D. .”
Cannabis Law Report
MAY 18, 2022
Observational Data Collected On Long-term Consumption of Oral C BD Shows No Correlation To Safety Issues Raised by FDA. Their participation strengthened the statistical reliability of both the liver safety results and achieved statistical relevance for both sleep and testosterone results.
Cannabis Law Report
MAY 18, 2022
NEW STUDY DEMONSTRATES CBD’S STRONG SAFETY PROFILE , AMPLIFIES CALLS FOR FDA REGULATION. Observational Data Collected On Long-term Consumption of Oral C BD Shows No Correlation To Safety Issues Raised by FDA. The second cohort included an additional 222 individuals taking CBD produced by an additional five companies.
Expert insights. Personalized for you.
52 
Let's personalize your content